We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-21.02%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.3M
AUM Growth
-$26.6M
Cap. Flow
-$16.7M
Cap. Flow %
-78.3%
Top 10 Hldgs %
66.69%
Holding
94
New
24
Increased
Reduced
32
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POL.WS
1
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$5.13M 24.13%
8,295,355
-153,900
-2% -$123K
TCBPW
2
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$1.38M 6.5%
+2,823,528
New +$1.31M
FATBW
3
DELISTED
FAT Brands Inc. Warrant
FATBW
$1.27M 5.95%
281,598
-18,402
-6% -$109K
BRCC.WS
4
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
$1.2M 5.65%
+269,212
New +$855K
SBFM
5
Sunshine Biopharma
SBFM
$4.92M
$1.1M 5.19%
+23
New +$1.12M
HCDIZ
6
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$1.08M 5.09%
2,930,730
-69,270
-2% -$30.3K
SRZN icon
7
Surrozen
SRZN
$283M
$1M 4.72%
22,264
-16,449
-42% -$813K
VLNS
8
DELISTED
The Valens Company, Inc. Common Shares
VLNS
$688K 3.23%
+400,000
New +$854K
ZEV.WS
9
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$663K 3.12%
676,381
-19,271
-3% -$18.9K
AIOS
10
AIOS Tech
AIOS
$56.5M
$658K 3.09%
3,363
-1,588
-32% -$432K
NTRBW icon
11
Nutriband Inc Warrant
NTRBW
$525K
$581K 2.73%
76,604
-3,396
-4% -$11.4K
HGTY.WS
12
DELISTED
Hagerty, Inc. Warrants, each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share
HGTY.WS
$522K 2.45%
178,758
-8,742
-5% -$37.7K
STLN
13
Starling Oncology
STLN
$645M
$504K 2.37%
70,733
-129,267
-65% -$872K
REED
14
DELISTED
Reeds, Inc. Common Stock
REED
$421K 1.98%
+28,000
New +$433K
BNCWW
15
CEA Industries Inc Warrant
BNCWW
$44.1K
$335K 1.57%
+500,000
New +$261K
SLNO
16
DELISTED
Soleno Therapeutics
SLNO
$313K 1.47%
+93,427
New +$484K
CALA
17
DELISTED
Calithera Biosciences, Inc
CALA
$313K 1.47%
+38,796
New +$396K
PEPLW
18
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$308K 1.45%
742,500
SURGW
19
DELISTED
SurgePays, Inc. Warrant
SURGW
$255K 1.2%
286,495
-13,505
-5% -$10.2K
SBFMW
20
Sunshine Biopharma Inc Warrant
SBFMW
$233K 1.1%
+235,200
New +$164K
CINGW icon
21
Cingulate Inc Warrants
CINGW
$21.4K
$200K 0.94%
500,000
DRCTW
22
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$194K 0.91%
+270,000
New +$152K
ARBEW icon
23
Arbe Robotics Warrant
ARBEW
$232K
$187K 0.88%
189,904
-10,096
-5% -$10.3K
WKSPW
24
DELISTED
Worksport, Ltd. Warrant
WKSPW
$143K 0.67%
193,370
-6,630
-3% -$4.92K
LEXXW
25
DELISTED
Lexaria Bioscience Warrant
LEXXW
$118K 0.55%
130,682
-2,651
-2% -$2.99K

Similar funds

Empery Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Empery Asset Management held 94 positions worth $21.3M, down 56% from $47.9M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Empery Asset Management withdrew a net $16.7M in Q1 2022, closing 17 positions and reducing 32 holdings. Its most notable exit was iSpecimen, an estimated $3.64M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Empery Asset Management opened a new position in TC BioPharm (Holdings) plc Warrants worth $1.38M.

  • Empery Asset Management's largest Q1 2022 buy was TC BioPharm (Holdings) plc Warrants: 2,823,528 shares worth $1.38M.
  • Empery Asset Management's biggest Q1 2022 reduction was Starling Oncology, cutting an estimated $872K.
  • Empery Asset Management fully exited iSpecimen in Q1 2022, selling an estimated $3.64M.
  • Empery Asset Management's ten largest holdings make up 67% of its $21.3M portfolio in Q1 2022.
  • Empery Asset Management opened 24 new positions and closed 17 in Q1 2022.
  • Empery Asset Management's portfolio value fell 56% quarter-over-quarter to $21.3M.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.